122 related articles for article (PubMed ID: 8023761)
1. [Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age].
Kanamaru H; Shirahase T; Isogawa Y; Moroi S; Okuno H; Kihara Y; Kuo JY; Taniguchi T; Arai Y
Hinyokika Kiyo; 1994 May; 40(5):387-92. PubMed ID: 8023761
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on the prognostic factors in prostate cancer].
Horii Y; Yoshida T; Hirai S; Yamauchi T
Hinyokika Kiyo; 1998 Oct; 44(10):701-5. PubMed ID: 9850833
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 169 patients with prostate cancer].
Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
[TBL] [Abstract][Full Text] [Related]
4. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
Tollefson MK; Leibovich BC; Slezak JM; Zincke H; Blute ML
J Urol; 2006 Feb; 175(2):547-51. PubMed ID: 16406993
[TBL] [Abstract][Full Text] [Related]
6. External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes.
Akimoto T; Kitamoto Y; Saito J; Harashima K; Nakano T; Ito K; Yamamoto T; Kurokawa K; Yamanaka H; Takahashi M; Mitsuhashi N; Niibe H
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):372-9. PubMed ID: 15145150
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer.
Ramos CG; Carvalhal GF; Smith DS; Mager DE; Catalona WJ
J Urol; 1999 May; 161(5):1525-9. PubMed ID: 10210388
[TBL] [Abstract][Full Text] [Related]
8. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
9. Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.
Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
J Urol; 2002 Aug; 168(2):509-13. PubMed ID: 12131299
[TBL] [Abstract][Full Text] [Related]
10. [Multivariate analysis of prognostic factors in patients with prostatic cancer].
Miyamoto T; Yuasa M; Furukawa A; Tamura M; Kawanishi Y; Numata A; Imagawa A; Kagawa S
Hinyokika Kiyo; 1991 Dec; 37(12):1663-8. PubMed ID: 1785390
[TBL] [Abstract][Full Text] [Related]
11. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of prostate cancer: statistical analysis of 107 cases in the past 12 years].
Umeda Y; Hayashi N; Ogawa K; Kuromatsu I; Franco OE; Su J; Yamakawa K; Arima K; Yanagawa M; Kawamura J
Hinyokika Kiyo; 2000 Dec; 46(12):873-8. PubMed ID: 11211803
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.
Helfand BT; Mongiu AK; Kan D; Kim DY; Loeb S; Roehl KA; Meeks JJ; Smith ND; Catalona WJ
BJU Int; 2009 Aug; 104(3):304-9. PubMed ID: 19239451
[TBL] [Abstract][Full Text] [Related]
16. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of prostate cancer--statistical analysis in the last 10 years].
Yamamoto N; Shimabukuro T; Matsuyama H; Yoshihiro S; Mitsui H; Sakatoku J
Hinyokika Kiyo; 1991 Jul; 37(7):705-10. PubMed ID: 1927770
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
[TBL] [Abstract][Full Text] [Related]
19. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
20. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
Fujikawa K; Sasaki M; Arai Y; Yamabe H; Ogawa O; Yoshida O
Clin Cancer Res; 1997 Apr; 3(4):613-8. PubMed ID: 9815728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]